ALX ONCOLOGY HOLDINGS INC - 10-Q Filing

ALX Oncology Holdings Inc reports Q3 2026 financial results including research and development expenses and updates on debt facilities.

SEC EDGAR ·

Tickers: $ALXO

Read the full article at SEC EDGAR

More Regulatory news